Bladder Cancer Trial, Recruiting (NCT00026884)

Bladder Cancer Trial, Recruiting NCT00026884 Sponsor: National Cancer Institute (NCI) Condition: Bladder Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT00026884 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Bladder Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with cancer confirmed by a biopsy (tissue sample)
You are suspected of having cancer, even if it has not been confirmed yet
You have or are suspected of having an inherited cancer condition affecting the urinary or reproductive system
You are 2 years of age or older
You are a blood relative of someone who has been diagnosed with, or is suspected of having, cancer or an inherited urinary/reproductive cancer condition
You (or your parent/guardian if you are under 18) must be willing and able to sign a consent form showing you understand the study and its risks before taking part

Who may not be able to join:

People whose other health conditions mean they would not be able to safely have surgery if needed (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: W. Marston Linehan, M.D., National Cancer Institute (NCI)

Phone: (240) 760-6247

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT00026884

Sponsor: National Cancer Institute (NCI)

Phase: Not Applicable

Status: Recruiting

Condition: Bladder Cancer

Trial contact: (240) 760-6247

More information: https://clinicaltrials.gov/study/NCT00026884

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with cancer confirmed by a biopsy (tissue sample)
You are suspected of having cancer, even if it has not been confirmed yet
You have or are suspected of having an inherited cancer condition affecting the urinary or reproductive system
You are 2 years of age or older
You are a blood relative of someone who has been diagnosed with, or is suspected of having, cancer or an inherited urinary/reproductive cancer condition
You (or your parent/guardian if you are under 18) must be willing and able to sign a consent form showing you understand the study and its risks before taking part

Who may not be able to join:

People whose other health conditions mean they would not be able to safely have surgery if needed (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

National Cancer Institute (NCI)

Registry

ClinicalTrials.gov

Start date

12 March 1998

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Investigate quality of life in men who have prostate cancer.; Investigate molecular genetic basis of urologic malignancies; Investigate cellular/biochemical response to existing and novel therapeutic agents.; Examine protein expression and bioimmunoassays investigating potential genetic markers.; Determine the molecular genetic differences between normal and tumorigenic tissues.; Collection of benign and malignant tissue from individuals with rare inherited conditions associated with an increased risk for kidney cancer.; Collection of benign and malignant tissue from individuals with known or...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov